Therefore, we review the role of the IL-6/STAT3 signaling pathway in HCC occurrence and development, and describe the current therapeutic strategies for targeting treatment of HCC in the IL-6/STAT3 signaling pathway. Here, STAT3 is linked to hepatocellular carcinoma.